Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun;13(6):309-23.
doi: 10.1038/nrurol.2016.62. Epub 2016 Apr 19.

Diagnosis and treatment of infertility-related male hormonal dysfunction

Martin Kathrins  1 , Craig Niederberger  2
Affiliations
Review

Diagnosis and treatment of infertility-related male hormonal dysfunction

Martin Kathrins et al. Nat Rev Urol. 2016 Jun.

Abstract

Treatment of infertility-related hormonal dysfunction in men requires an understanding of the hormonal basis of spermatogenesis. The best method for accurately determining male androgenization status remains elusive. Treatment of hormonal dysfunction can fall into two categories - empirical and targeted. Empirical therapy refers to experience-based treatment approaches in the absence of an identifiable aetiology. Targeted therapy refers to the correction of a specific underlying hormonal abnormality. However, the tools available for inferring the intratesticular hormonal environment are unreliable. Thus, understanding the limitations of serum hormonal assays is very important for determining male androgen status. Furthermore, bulk seminal parameters are notoriously variable and consequently unreliable for measuring responses to hormonal therapy. In the setting of azoospermia owing to spermatogenic dysfunction, hormonal therapy - relying on truly objective parameters including the return of sperm to the ejaculate or successful surgical sperm retrieval - is a promising treatment. This approach to the treatment of fertility-related hormonal dysfunction in men contrasts with the current state of its counterpart in female reproductive endocrinology. Treatment of male hormonal dysfunction has long emphasized empirical therapy, whereas treatment of the corollary female dysfunction has been directed at specific deficits.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ther Clin Risk Manag. 2015 Jun 29;11:995-1001 - PubMed
    1. J Clin Endocrinol Metab. 2002 Aug;87(8):3702-7 - PubMed
    1. Fertil Steril. 2010 May 1;93(7):2232-5 - PubMed
    1. Mol Cell Endocrinol. 2007 Apr 15;269(1-2):81-4 - PubMed
    1. Clin Chem. 2006 Sep;52(9):1777-84 - PubMed

Publication types

LinkOut - more resources